SUMMARY Hypercoagulability may contribute to stroke in young adults. Lupus anticoagulants (LA) were identified in six patients (4%) of 145 young adults with cerebral infarction. The clinical features of the 6 patients in this survey plus an additional patient from another institution with LA-associated stroke are presented. Four had systemic lupus erythematosus and 3 had idiopathic LA; all had mild thrombocytopenia. In 2 patients, no other conditions associated with stroke were discovered after thorough evaluation. Recurrent arterial thrombosis occurred in 4 of 7 patients during an average of two years of follow-up. Evidence suggests that inhibition of prostacyclin formation may occur with LA, promoting a prothrombotic state.
Stroke Vol 15, No I, 1984 LUPUS ANTICOAGULANTS (LA) are acquired IgG or IgM immunoglobulins which inhibit coagulation by interfering with the phospholipid portion of the prothrombin activator complex. 1 2 Although it initially described in patients with systemic lupus erythematosus (SLE) 30 years ago, they have been associated with the use of phenothiazines, non-SLE autoimmune disease, neoplasms, and drug-induced lupus as well as occurring idiopathically.
1 " 5 The laboratory hallmark is a prolonged partial thromboplastin time (PTT) which fails to normalize when affected plasma is mixed with normal plasma. Additionally, mild thrombocytopenia and a false-positive VDRL are often associated with LA.
Despite their function as in vitro anticoagulants, LA are, paradoxically, most often associated with thrombosis and not abnormal bleeding. 6 Mueh et al recently reported thrombotic events in eight of 35 patients with LA. 4 Most clinical events have involved venous thromboembolism, but arterial thrombosis with attendant stroke (3 patients) and TIA (3 patients) has been reported.
2 -4 -7 - 9 We report the clinical features of cerebral infarction associated with LA occurring in seven young adults. Of these patients, 6 were identified in a retrospective, population-based survey of 145 young adults with ce- rebral infarction. 10 In two patients, the absence of other conditions associated with stroke suggests a role of LA in the etiology of cerebral infarction.
Methods
There were 6 patients (4%) with LA identified in a retrospective survey of hospital records of 145 young adults (age less than 40) who had cerebral infarction which occurred during the years 1975-1981 at 10 hospitals in Portland, Oregon. A prolonged PTT was the initial evidence that led to further characterization. Many patients with an obvious cause of stroke (eg., prosthetic valve) were not screened with a PTT.
Cerebral infarction was defined as the abrupt onset of a persistent focal neurologic deficit without hemorrhage on computed tomography (CT). Patients with slowly (over hours) evolving deficits or deficits associated with seizures, diffuse encephalopathy or abnormalities of the cerebrospinal fluid (CSF) were excluded to avoid inclusion of patients with lupus cerebritis. LA were considered to be present when the initial two criteria of table 1A were present. In 4 patients, all three criteria were met. Further hematologic testing to fulfill all criteria was not possible in the remaining two patients who were lost to follow-up. An additional patient (VB) was not part of the retrospective survey but was identified at another center.
Results
Our survey of cerebral infarction in patients 40 years-old or less revealed that at least 6 (4%) had LA. With the additional patient with LA and stroke who was not part of this survey, clinical information is available for seven patients (table 2 ). There were 6 females and one male. All had mild thrombocytopenia. Four patients with stroke and LA also had SLE; stroke was the presenting feature of SLE in 3 of these patients. Two patients with SLE had false-positive VDRL tests for syphilis. One patient had clinical venous thrombosis, and another had multiple new and old pulmonary emboli at postmortem examination. In patients with idiopathic LA, two were receiving no medications and one had recently started oral contraceptives at the time of the initial stroke. The LA persisted after cessation of oral contraceptives in this last patient.
Other conditions that may predispose to cerebral infarction were seen in five patients (table 2) : mitral valve prolapse, classic migraine, recent initiation and recent discontinuation of oral contraceptive use and a combination of marantic endocarditis and atherosclerosis were each found in one patient. Follow-up was brief, averaging only two years, but four patients (56%) experienced recurrent ischemia (table 3) . Three recurrent episodes involved the brain and one an extremity.
Three illustrative patients are described:
Case 1 DG was a previously healthy 35 year-old man who experienced sudden right hemiparesis and aphasia. There was no history of migraine or substance abuse. General physical examination, complete blood count, EK.G and echocardiography were normal. No coagulation studies were initially done. Cerebral arteriography revealed multiple branch artery occlusions of the left middle cerebral artery. Deficits slowly improved, although residual hemiparesis and nonfluent dysphasia were permanent. A platelet number estimate by peripheal smear, done six months later at the time of elective circumcision, was slightly low. He was started on phenytoin after a generalized convulsion one year after stroke. Five years later, he complained of sudden headache and was found to be confused with garbled speech. Neurological examination revealed the residua of his prior stroke plus severe dysarthria. Anti-nuclear antibody (ANA) testing, serum complement levels, LE preparation, protein electrophoresis, prothrombin time (FT), CSF examination and cerebral arteriography were all normal. Platelet count was 110,000 (normal > 150,000). CT scan showed bilateral hypodense areas consistent with cerebral infarctions. Cardiology consultation, EKG and echocardiography again disclosed no abnormalities of the heart. He was treated with aspirin and dipyridamole, but he was known to be poorly compliant.
Two years later (seven years after his first stroke) he experienced sudden worsening of right hemiparesis. General examination was again normal. Complete blood counts were normal except for a platelet count of 78,000. The PTT was 57.8 seconds (normal <40 seconds) and incompletely corrected with a 1:1 dilution with normal plasma. Prothrombin time was minimally prolonged at 14.1 seconds (control was 12 seconds). Tissue thromboplastin dilution test was abnormal, indicative of a circulating anticoagulant. Erythrocyte sedimentation rate (ESR) was 12 mm/hr. Serum ANA, rheumatoid factor, serum cryoglobulin titers and protein electrophoresis were again normal. Antiplatelet antibodies were not detected by direct or indirect immunoflorescent techniques. Echocardiography and cerebral arteriography were again normal. CT (figure 1) showed multiple, bilateral cerebral hypodensities. The prolonged PTT persisted after discontinuation of phenytoin.
Comment: The presence of LA was only appreciated during evaluation of the third episode of stroke, as no PTT was done on prior evaluations. Longstanding thrombocytopenia, however, suggests that LA may have been present during the initial strokes. No other conditions associated with recurrent cerebral infarction were identified despite extensive search.
Case 2
SH was a 40 year-old left-handed woman who experienced sudden headache and trouble speaking. Six years earlier she had a spontaneous abortion, at which time her PTT was normal and ANA were absent. There was a history of hypertension and migratory polyarthralgias. Physical examination was remarkable for a malar rash and alexia without agraphia. Extensive laboratory investigation included a hemoglobin of 15 gm/ dl, an ESR of 50 mm/hr, PTT of 73.1 seconds without corection with 1:1 dilution with normal plasma, absent ANA and anti-DNA antibodies on repeated testing, absent cryoglobulins, normal serum protein electrophoresis, and negative rheumatoid factor and VDRL. Dilute tissue thromboplastin inhibition testing was indicative of a circulating anticoagulant. Serum complement and fibrinogen levels were normal; fibrin degradation products were minimally present. There was moderate proteinuria (1 gram/24 hours). CSF examination, CT scan and echocardiography were normal. Platelet aggregation responses and beta-thromboglobulin assay were normal. Cerebral arteriography showed moderate (50%) stenoses of the origins of both internal carotid arteries as the only abnormalities.
She was treated with prednisone (60 mg/day) for presumed sero-negative SLE. Repeat laboratory studies one month later revealed an ESR of 34 mm/hr, PTT of 38 seconds and persistent proteinuria. Renal biopsy revealed a mixed membranous and mesangioproliferative glomerulonephritis with heavy mesangial deposits of IgG and IgA by immunofluorescent staining consistent with SLE.
Nine months after her initial stroke she experienced a sudden seizure-like event and was re-evaluated. Neurological examination was normal except for persistent alexia. PTT was 44 seconds and moderate proteinuria persisted. Complement titers, ANA titers, anti-DNA antibody assay and CSF were normal. A CT scan revealed a new hypodense area in the left cerebellum. A purpuric skin lesion was biopsied but no evidence of vasculitis was found. Azathioprine was started (150 mg/day). Her PTT remained persistently elevated (50 seconds) on follow-up testing.
Thirteen months after the initial stroke she underwent urgent laparotomy for an acute abdomen. PTT was 63 seconds, ESR was 47 mm/hr, platelet count was 117,000, PT was 12 seconds, and red blood cell morphology was normal. An infarcted colon was resected, but the patient rapidly succumbed to septic shock postoperatively.
Autopsy showed atherosclerotic vascular disease involving the coronary, carotid and renal arteries as well as the aorta. A 3 mm noninfective (marantic) vegetation was present on the mitral valve without accompanying inflammation or necrosis of valvular ground substance. Multiple areas of small infarction of varying age were present in the myocardium and cerebral cortex, the largest involving 2 cm of cortex. Thrombotic occlusion of small vessels was seen in many organs, including the brain. However, there was no inflammation of the adjacent vessel walls. There was minimal atherosclerotic involvement of the intracranial arteries.
Comment: The PTT fluctuated during the course of her illness but was most elevated during clinical thrombotic episodes. Despite the repeatedly negative testing for ANA during active disease, her illness was typical of SLE with associated lupus anticoagulants.
Case 3
CP was a 23 year-old woman who presented with sudden left hemiparesis and ataxia. For six months prior to admission she had livedo reticularis involving arms and legs, and recurrent episodes of pleuritic chest pain. She had used oral contraceptives intermittently for three years, and discontinued this medication one week before admission. Hypertension (BP 220/130 mm Hg) was noted on admission as well as livedo reticularis, but her general physical examination was otherwise unremarkable. Initial CT scan of the head was normal. Chest x-ray, EKG, and two-dimensional (2D) echocardiogram were normal. Hemoglobin, white cell count, serum electrolytes, VDRL, CSF studies and serum complement levels were all normal. Platelet count was 110,000/mm. 3 ESR was 12 mm/hr. ANA, LE celi preparations and anti-DNA assay were normal. Prothrombin time was normal, but PTT was prolonged (patient = 43 sec, control = 29 sec) with failure to correct on mixing with normal plasma. Renal biopsy showed a proliferative glomerulopathy with mesangial IgM deposits.
Cerebral arteriography showed a branch occlusion of the right middle cerebral artery. Repeat CT demonstrated a lucent area in the right internal capsule. PTTs remained prolonged during treatment with dipyridamole and sulfinpyrazone.
Three weeks after her stroke, she developed left leg swelling and pain. Venography revealed extensive old and recent thromboses. She was placed on anticoagulants but was lost to follow-up shortly thereafter.
Discussion
The association of LA and cerebral infarction, as described in our patients, does not necessarily imply a cause and effect. About 10% of all patients with SLE have LA. Patients with SLE have many reasons for stroke, including inflammatory arteritis, cortical vein thrombosis, Libman-Sacks or infective endocarditis with embolism, other coagulation and fibrinolytic aberrancies, 7 -9 -" and atherosclerosis related to frequent coexistence of hypertension. Further, sudden onset of relatively focal cerebritis may simulate large or medium-sized vessel occlusion and be difficult to clinically distinguish from conventional cerebral infarction.
However, Carreras et al have shown that plasma from many patients with LA inhibits production of prostacyclin -a potent vasodilator and platelet antiaggregant.
2 l2 Inhibition of prostacyclin formation by LA might well predispose to thrombosis, as suggested by several investigators.
2 -12 -' 3 In two of our patients (DS, TS), no other conditions predisposing to cerebral infarction were discovered after thorough evaluation except idiopathically occurring LA.
Correlation between the degree of elevation of PTT, quantitative titer of inhibitor and/or other laboratory features of LA with propensity for thrombosis has not been clearly established. Carreras and Vermylen reported an average 2.4 times prolongation of PTT in four LA patients with recurrent thrombosis, 2.2 times in four LA patients with single thrombotic events, and 1.8 times in six LA patients without thrombosis. 2 Meuh et al reported an average prolongation of PTT by a factor of 2.2 in two LA patients with arterial thrombosis and by 1.7 in six LA patients with venous thrombosis. 4 Our patients with cerebral infarction had an average increase in PTT by a factor of 2.0. Carreras and Vermylen preliminarily reported that inhibition of prostacyclin production correlated with degree of prolongation of PTT (p < 0.015) and presence of thrombosis (p < 0.20). 2 Although thrombocytopenia is seen in 30% of all patients with the LA, 4 four of eight patients with LA and thrombosis in Mueh et al's series 4 and all of our patients had thrombocytopenia. Elevation of factor VIII, LA, thrombocytopenia and stroke have been seen in one patient. sion in SLE as well as in small vessels in lupus cerebritis." Altered coagulability with in situ thrombosis or embolism could explain these nonvasculitic occlusions.
In our retrospective survey, at least 6 of 145 (4%) of young adults with cerebral infarction had LA. The cause of stroke in young adults is often unclear, even after thorough evaluation seeking known conditions predisposing to stroke. 10 The PTT may fluctuate to within the normal range in patients with LA and may not be an ever-present marker of these antibodies (as in patient SH). Further, the sensitivity of PTT in detecting the LA has been shown to be reagent dependent, 13 and more easily detectable when platelet counts are low. 13 Kaolin clotting time may be a more sensitive screening test than PTT for LA. 2 -16 Lupus anticoagulants are present in older patients, most of whom do not have SLE. 14 We have recently evaluated a 71 year-old man with multiple, bilateral cerebral infarctions occurring over 2 years in association with LA. Bilateral carotid endarterectomies were done for minimal bifurcation plaques but with subsequent recurrent stroke.
Other disorders of coagulation associated with stroke may superficially mimic LA. Diffuse intravascular coagulation (DIC) is an acquired syndrome of hemorrhage and thrombosis that occurs in a variety of diseases.
n It is an acute or chronic consumptive coagulopathy with neurologic involvement ranging from diffuse encephalopathy to brain infarction and hemorrhage. Laboratory hallmarks are a prolonged PT, thrombocytopenia, hypofibrinogenemia and elevated fibrinogen degradation products. The PTT is frequently prolonged in DIC, but usually corrects when diluted with normal plasma. Large artery occlusions in DIC patients have frequently coexisted with nonbacterial thrombotic (marantic) endocarditis with presumed embolism. 17 Thrombotic thrombocytopenic purpura (TTP) may present with stroke but is not easily confused with LA. TTP is usually a malignant syndrome with microangiopathic hemolytic anemia, fever, renal impairment and neurologic dysfunction.' 8 Thrombocytopenia is usually marked, anemia is invariable, and PTT is normal in 94% of TTP patients. 18 Chronic and/or recurrent TTP is rare but may be associated with minimal anemia and thrombocytopenia; coagulation studies have been normal. 19 Other conditions which may superficially resemble LA include occult, low-dose heparin administration, vitamin K deficiency, severe liver disease and improper collection of blood (partial clotting).
With etiologic uncertainty surrounding the association of LA and cerebral infarction, appropriate treatment of such patients is unclear. Recurrent arterial thrombosis has occurred disturbingly often, Anticogulants have been used in patients with recurrent deep venous thrombosis associated with LA. 4 Based on the possible mechanism of prostacyclin inhibition, aspirin therapy may be empirically advised until further data are forthcoming. 20 -21 
